We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Sen. Scott Wiener (D-San Francisco) has introduced two bills in the State Senate that could lower prescription drug prices ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

The bill's supporters framed it as part of the solution to addressing both high drug prices and slowing the pace of pharmacy ...

The program, created under the Inflation Reduction Act (IRA), allows the federal government to negotiate the prices of some of the costliest Medicare Part D drugs directly with drug companies.

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

Pharmacy benefit managers, insurance companies, and pharmacists debated the causes and potential impacts of the new proposal ...

DES MOINES — High prescription drug costs and pharmacies going out of business, especially in rural Iowa, have once again put pharmacy benefit managers — the companies that function as ...